DR. ROBERT CAMPBELL MCINTYRE, M.D.
Marriage and Family Therapists at Madison St, Seattle, WA

License number
Washington MD00018146
Category
Osteopathic Medicine
Type
Family Medicine
Address
Address
2001 E Madison St, Seattle, WA 98122
Phone
(206) 328-7722
(206) 720-4657 (Fax)

Personal information

See more information about ROBERT CAMPBELL MCINTYRE at radaris.com
Name
Address
Phone
Robert Mcintyre
5512 Chelan Ln SE, Lacey, WA 98503
(360) 438-9720
Robert L Mcintyre, age 87
5229 312Th St, Auburn, WA 98001
Robert L Mcintyre
4582 Woodland Cir, Oak Harbor, WA 98277
Robert L Mcintyre
180 Ferncrest Rd, Longview, WA 98632

Professional information

Robert Mcintyre Photo 1

Senior Program Manager At Microsoft

Position:
Senior Security Program Manager at Microsoft
Location:
Greater Seattle Area
Industry:
Computer Software
Work:
Microsoft - Redmond, WA since Jun 2000 - Senior Security Program Manager US Navy Aug 1988 - Aug 1996 - Electrician's Mate
Education:
Edmonds Community College 2012 - 2012
Certificate, Digital Forensics
North Carolina State University 1996 - 2000
BS - Electrical Engineering, BS - Computer Engineering
Certifications:
Cyber Security Forensic Analyst, CyberSecurity Institute
Certified Data Recovery Expert, MHDD


Robert Campbell Mcintyre Photo 2

Robert Campbell McIntyre, Seattle WA

Specialties:
Family Physician
Address:
2001 E Madison St, Seattle, WA 98122
Education:
George Washington University, Medical School - Doctor of Medicine
University Health Care - Residency - Family Medicine
Board certifications:
American Board of Family Medicine Certification in Family Medicine


Robert C Mcintyre Photo 3

Dr. Robert C Mcintyre, Kent WA - MD (Doctor of Medicine)

Specialties:
Family Medicine
Address:
Planned Parenthood
10056 SE 240Th St SUITE A, Kent 98031
(253) 520-5611 (Phone)
Planned Parenthood Great NW
2001 E Madison St, Seattle 98122
(800) 230-7526 (Phone)
Planned Parenthood Great NW
402 Legion Way SE SUITE 201, Olympia 98501
(360) 754-5522 (Phone)
Certifications:
Family Practice, 1999
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
George Washington University / School of Medicine And Health Sciences
University Of Utah


Robert Mcintyre Photo 4

Enhanced Production Of Antibodies Utilizing Insolubilized Immune Complexes

US Patent:
5084396, Jan 28, 1992
Filed:
Sep 7, 1990
Appl. No.:
7/579627
Inventors:
A. Charles Morgan - Edmonds WA
Clive S. Woodhouse - Seattle WA
Robert F. McIntyre - Seattle WA
Assignee:
Neorx Corporation - Seattle WA
International Classification:
G01N 33563, A61K 3900
US Classification:
436513
Abstract:
A method for enhancing production of antibodies through immunization with insolubilized immune complexes is disclosed. Purified antigen or heterogeneous antigen mixtures may be combined with polyclonal or monoclonal antibody and the resultant complex bound to an insolubilized matrix to form insolubilized immune complexes. Methods for improving the immunogenicity of a soluble antigen and for producing monoclonal anti-iodiotypic antibodies are also disclosed. Monoclonal antibodies that are specific for a distinct, as yet unrecognized epitope may be produced by another disclosed method. Insolubilized immune complexes, comprising antigen and antibody that is ether directly linked to Sepharose. RTM. or absorbed onto insolubilized protein A, and immunosorbents, comprising antibody absorbed onto insolubilized protein A, are also disclosed.


Robert Mcintyre Photo 5

Enhanced Production Of Antibodies Utilizing Insolubilized Immune Complexes

US Patent:
4879225, Nov 7, 1989
Filed:
Mar 11, 1987
Appl. No.:
7/024632
Inventors:
Alton C. Morgan - Edmonds WA
Clive S. Woodhouse - Seattle WA
Robert F. McIntyre - Seattle WA
Assignee:
NeoRx Corporation - Seattle WA
International Classification:
C12P 2100, C12N 500, C12N 1500, A61K 3900
US Classification:
435 68
Abstract:
A method for enhancing production of antibodies through immunization with insolubilized immune complexes is disclosed. Purified antigen or heterogeneous antigen mixtures may be combined with polyclonal or monoclonal antibody and the resultant complex bound to insolubilized protein A to form insolubilized immune complexes. Methods for improving the immunogenicity of a soluble antigen and for producing monoclonal anti-idiotypic antibodies are also disclosed. Monoclonal antibodies that are specific for a distinct, as yet unrecognized epitope may be produced by another disclosed method. Insolubilized immune complexes, comprising antigen and antibody that is either directly linked to Sepharose. RTM. or absorbed onto insolubolized protein A, and immunosorbents, comprising antibody absorbed onto insolubilized protein A, are also disclosed.


Robert Mcintyre Photo 6

Method For Improving The Elicitation Of Igg Class Monoclonal Antibodies To Tumor-Associated Antigens And Glycoproteins

US Patent:
4822734, Apr 18, 1989
Filed:
Sep 6, 1985
Appl. No.:
6/773340
Inventors:
Alton C. Morgan - Edmonds WA
Robert McIntyre - Seattle WA
Clive S. Woodhouse - Edmonds WA
Paul G. Abrams - Seattle WA
Assignee:
NeoRx Corporation - Seattle WA
International Classification:
C12P 2100, C12N 1500, C12N 500, A61K 3900
US Classification:
435 68
Abstract:
Methods are disclosed for improving the efficiency of elicitation of monoclonal antibodies to glycoprotein antigens and tumor-associated antigens, and for inducing the production of IgG class monoclonal antibodies, in particular the IgG. sub. 3 subclass. The methods involve the use of a lectin/extract immunogen to stimulate the production of the desired monoclonal antibodies.


Robert Mcintyre Photo 7

Method Of Enhancing Immunoglobulin Fragment Production

US Patent:
5099005, Mar 24, 1992
Filed:
Sep 28, 1990
Appl. No.:
7/589984
Inventors:
Everett J. Nichols - Edmonds WA
Robert F. McIntyre - Seattle WA
Assignee:
NeoRx Corporation - Seattle WA
International Classification:
C07K 308
US Classification:
5303881
Abstract:
Methods of enhancing immunoglobulin fragment yield of immunoglobulins exhibiting anomalous bands when analyzed by SDS-PAGE techniques are provided. Such yield enhancement methods include the steps of desialylating the immunoglobulin; and fragmenting the immunoglobulin produced in the desialylating step. A particular advantage of the present invention is that the fragmention step can be carried out in the presence of cysteine without decreasing the quality of the immunoglobulin fragment product. Methods of enhancing the molecular weight homogeneity of immunoglobulin or fragmented immunoglobulin exhibiting anomalous bands when analyzed by SDS-PAGE techniques are also discussed. These methods include the steps of desialylating the immunoglobulin or fragmented immunoglobulin and purifying the desialylated product.